Skip to main
IPX

IperionX Ltd (IPX) Stock Forecast & Price Target

IperionX Ltd (IPX) Analyst Ratings

Based on 2 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

IperionX Ltd is positioned for growth as it successfully enhances its 2029 EBITDA estimate multiple from 7x to 8x, reflecting the company's ongoing advancements in production capabilities. The company's unique focus on sustainable titanium technologies aligns with increasing market demands for low carbon intensity products, contributing to a favorable valuation outlook. Additionally, the improvement in future dilution assumptions supports a higher valuation as IperionX scales its operations and revenue through innovative processes at its pilot facility and the Titan Project in Tennessee.

Bears say

IperionX Ltd is facing substantial operational and technical risks inherent in the natural resource and industrial sectors, which may adversely affect its performance. Additionally, the company is exposed to commodity price risks that could impact profitability and market competitiveness. Moreover, potential obstacles such as permitting or construction delays, capital overruns, and difficulties in gaining market share could further hinder IperionX's ability to realize its financial objectives and growth potential.

IperionX Ltd (IPX) has been analyzed by 2 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of IperionX Ltd and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About IperionX Ltd (IPX) Forecast

Analysts have given IperionX Ltd (IPX) a Strong Buy based on their latest research and market trends.

According to 2 analysts, IperionX Ltd (IPX) has a Strong Buy consensus rating as of Jan 14, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $51, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $51, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

IperionX Ltd (IPX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.